Seqker Biosciences, Inc.

This study tested a personalized vaccine made from each patient's unique cancer mutations (neoantigens) in 8 adults with advanced solid tumors or high risk of recurrence. The vaccine aims to train the immune system to recognize and attack cancer cells. Researchers checked for saf…